Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Press Releases

Filter articles using the following links
  • Financial press releases
  • Events & presentations
13 January 2021

GenSight Biologics Announces Publication of Results from LUMEVOQ® RESCUE Pivotal Phase III Trial in AAO journal Ophthalmology®

20 Feb 2021 - 23 Feb 2021

47th NANOS Annual Meeting – Virtual Meeting

11 Jan 2021 - 14 Jan 2021

39th Annual J.P. Morgan Healthcare Conference – Virtual

10 December 2020

GenSight Biologics announces the partial conversion of convertible bonds and full exercise of share warrants by Kreos Capital

10 December 2020

GenSight Biologics Announces Publication of Results from LUMEVOQ® REVERSE Pivotal Phase III Trial and Non-Human Primate Study in Science Translational Medicine

15 November 2020

Article – EN

16 Nov 2020 - 17 Nov 2020

Bryan Garnier European Healthcare Conference 2020 – virtual event

13 Nov 2020 - 15 Nov 2020

American Academy of Ophthalmology 2020 – Virtual

03 November 2020

GenSight Biologics reports validation of LUMEVOQ® Marketing Authorisation Application (MAA) by European Medicines Agency

06 Nov 2020

Eyecelerator 2020 – Virtual Conference

  • View previous 9 articles
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 42
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page